BRPI0605795B1 - sistema de formação de imagem de pele com prova - Google Patents
sistema de formação de imagem de pele com prova Download PDFInfo
- Publication number
- BRPI0605795B1 BRPI0605795B1 BRPI0605795A BRPI0605795A BRPI0605795B1 BR PI0605795 B1 BRPI0605795 B1 BR PI0605795B1 BR PI0605795 A BRPI0605795 A BR PI0605795A BR PI0605795 A BRPI0605795 A BR PI0605795A BR PI0605795 B1 BRPI0605795 B1 BR PI0605795B1
- Authority
- BR
- Brazil
- Prior art keywords
- skin
- probe
- images
- camera
- image
- Prior art date
Links
- 238000003384 imaging method Methods 0.000 title claims abstract description 32
- 239000000523 sample Substances 0.000 claims abstract description 74
- 238000000034 method Methods 0.000 claims abstract description 40
- 239000000835 fiber Substances 0.000 claims description 17
- 230000015572 biosynthetic process Effects 0.000 claims description 13
- 230000005284 excitation Effects 0.000 claims description 11
- 238000001506 fluorescence spectroscopy Methods 0.000 claims description 7
- 230000004913 activation Effects 0.000 claims description 6
- 238000001055 reflectance spectroscopy Methods 0.000 claims description 6
- 230000003213 activating effect Effects 0.000 claims description 3
- 230000003068 static effect Effects 0.000 claims description 3
- 238000012360 testing method Methods 0.000 abstract description 23
- 238000012552 review Methods 0.000 abstract description 7
- 238000005286 illumination Methods 0.000 abstract description 5
- 230000001360 synchronised effect Effects 0.000 abstract description 2
- 230000001755 vocal effect Effects 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 139
- 230000010287 polarization Effects 0.000 description 28
- 238000004590 computer program Methods 0.000 description 23
- 206010000496 acne Diseases 0.000 description 14
- 230000001976 improved effect Effects 0.000 description 13
- 208000002874 Acne Vulgaris Diseases 0.000 description 11
- 206010040954 Skin wrinkling Diseases 0.000 description 11
- 238000012545 processing Methods 0.000 description 10
- 230000037303 wrinkles Effects 0.000 description 10
- 230000004044 response Effects 0.000 description 9
- 208000012641 Pigmentation disease Diseases 0.000 description 8
- 238000009792 diffusion process Methods 0.000 description 8
- 206010015150 Erythema Diseases 0.000 description 7
- 238000004458 analytical method Methods 0.000 description 7
- 230000008901 benefit Effects 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 230000019612 pigmentation Effects 0.000 description 7
- 238000001228 spectrum Methods 0.000 description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- 208000010305 Epidermal Cyst Diseases 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 6
- 238000009826 distribution Methods 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- 210000004209 hair Anatomy 0.000 description 6
- 238000003825 pressing Methods 0.000 description 6
- 230000005855 radiation Effects 0.000 description 6
- VYGQUTWHTHXGQB-FFHKNEKCSA-N retinyl palmitate Natural products CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 6
- 239000013543 active substance Substances 0.000 description 5
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 5
- 239000003963 antioxidant agent Substances 0.000 description 5
- 235000006708 antioxidants Nutrition 0.000 description 5
- 230000000712 assembly Effects 0.000 description 5
- 238000000429 assembly Methods 0.000 description 5
- 238000010586 diagram Methods 0.000 description 5
- 239000000284 extract Substances 0.000 description 5
- 230000001815 facial effect Effects 0.000 description 5
- 239000011148 porous material Substances 0.000 description 5
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 4
- 239000002537 cosmetic Substances 0.000 description 4
- 238000013461 design Methods 0.000 description 4
- 230000005684 electric field Effects 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 230000008447 perception Effects 0.000 description 4
- 150000004032 porphyrins Chemical class 0.000 description 4
- 229940108325 retinyl palmitate Drugs 0.000 description 4
- 235000019172 retinyl palmitate Nutrition 0.000 description 4
- 239000011769 retinyl palmitate Substances 0.000 description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 4
- 238000005070 sampling Methods 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- 238000012800 visualization Methods 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- 102000008186 Collagen Human genes 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- 206010012426 Dermal cyst Diseases 0.000 description 3
- 206010025421 Macule Diseases 0.000 description 3
- 241000695776 Thorichthys aureus Species 0.000 description 3
- 238000000862 absorption spectrum Methods 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 210000000736 corneocyte Anatomy 0.000 description 3
- -1 energy improvers Substances 0.000 description 3
- 231100000321 erythema Toxicity 0.000 description 3
- 230000010354 integration Effects 0.000 description 3
- 230000007794 irritation Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000000985 reflectance spectrum Methods 0.000 description 3
- 238000012549 training Methods 0.000 description 3
- 230000001960 triggered effect Effects 0.000 description 3
- 230000000007 visual effect Effects 0.000 description 3
- 230000003442 weekly effect Effects 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- 239000004342 Benzoyl peroxide Substances 0.000 description 2
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 2
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 2
- 241000186427 Cutibacterium acnes Species 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 description 2
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 2
- 230000037338 UVA radiation Effects 0.000 description 2
- 235000010724 Wisteria floribunda Nutrition 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- ZSLZBFCDCINBPY-ZSJPKINUSA-N acetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 239000003212 astringent agent Substances 0.000 description 2
- 235000019400 benzoyl peroxide Nutrition 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 235000017471 coenzyme Q10 Nutrition 0.000 description 2
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 238000010304 firing Methods 0.000 description 2
- 210000001061 forehead Anatomy 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 230000003779 hair growth Effects 0.000 description 2
- 230000036571 hydration Effects 0.000 description 2
- 238000006703 hydration reaction Methods 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 150000001261 hydroxy acids Chemical class 0.000 description 2
- 238000002329 infrared spectrum Methods 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- AGBQKNBQESQNJD-UHFFFAOYSA-M lipoate Chemical compound [O-]C(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-M 0.000 description 2
- 235000019136 lipoic acid Nutrition 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 2
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 2
- 229960003512 nicotinic acid Drugs 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 2
- 235000021283 resveratrol Nutrition 0.000 description 2
- 229940016667 resveratrol Drugs 0.000 description 2
- 229960004889 salicylic acid Drugs 0.000 description 2
- 208000017520 skin disease Diseases 0.000 description 2
- 230000005808 skin problem Effects 0.000 description 2
- 230000036555 skin type Effects 0.000 description 2
- 230000000475 sunscreen effect Effects 0.000 description 2
- 239000000516 sunscreening agent Substances 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 229960002663 thioctic acid Drugs 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 229910052724 xenon Inorganic materials 0.000 description 2
- FHNFHKCVQCLJFQ-UHFFFAOYSA-N xenon atom Chemical compound [Xe] FHNFHKCVQCLJFQ-UHFFFAOYSA-N 0.000 description 2
- IZFHEQBZOYJLPK-SSDOTTSWSA-N (R)-dihydrolipoic acid Chemical compound OC(=O)CCCC[C@@H](S)CCS IZFHEQBZOYJLPK-SSDOTTSWSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- GJJVAFUKOBZPCB-ZGRPYONQSA-N (r)-3,4-dihydro-2-methyl-2-(4,8,12-trimethyl-3,7,11-tridecatrienyl)-2h-1-benzopyran-6-ol Chemical class OC1=CC=C2OC(CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)(C)CCC2=C1 GJJVAFUKOBZPCB-ZGRPYONQSA-N 0.000 description 1
- WKBPZYKAUNRMKP-UHFFFAOYSA-N 1-[2-(2,4-dichlorophenyl)pentyl]1,2,4-triazole Chemical compound C=1C=C(Cl)C=C(Cl)C=1C(CCC)CN1C=NC=N1 WKBPZYKAUNRMKP-UHFFFAOYSA-N 0.000 description 1
- INGWEZCOABYORO-UHFFFAOYSA-N 2-(furan-2-yl)-7-methyl-1h-1,8-naphthyridin-4-one Chemical compound N=1C2=NC(C)=CC=C2C(O)=CC=1C1=CC=CO1 INGWEZCOABYORO-UHFFFAOYSA-N 0.000 description 1
- WSSJONWNBBTCMG-UHFFFAOYSA-N 2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C1=CC=CC=C1O WSSJONWNBBTCMG-UHFFFAOYSA-N 0.000 description 1
- UOQHWNPVNXSDDO-UHFFFAOYSA-N 3-bromoimidazo[1,2-a]pyridine-6-carbonitrile Chemical compound C1=CC(C#N)=CN2C(Br)=CN=C21 UOQHWNPVNXSDDO-UHFFFAOYSA-N 0.000 description 1
- 208000020154 Acnes Diseases 0.000 description 1
- 244000144927 Aloe barbadensis Species 0.000 description 1
- 235000002961 Aloe barbadensis Nutrition 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- 108010078791 Carrier Proteins Proteins 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 235000004866 D-panthenol Nutrition 0.000 description 1
- 239000011703 D-panthenol Substances 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
- 206010012444 Dermatitis diaper Diseases 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 208000003105 Diaper Rash Diseases 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 239000004266 EU approved firming agent Substances 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 208000035874 Excoriation Diseases 0.000 description 1
- YPZRHBJKEMOYQH-UYBVJOGSSA-L FADH2(2-) Chemical compound C1=NC2=C(N)N=CN=C2N1[C@@H]([C@H](O)[C@@H]1O)O[C@@H]1COP([O-])(=O)OP([O-])(=O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C(NC(=O)NC2=O)=C2NC2=C1C=C(C)C(C)=C2 YPZRHBJKEMOYQH-UYBVJOGSSA-L 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- MVORZMQFXBLMHM-QWRGUYRKSA-N Gly-His-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CN=CN1 MVORZMQFXBLMHM-QWRGUYRKSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 241000208680 Hamamelis mollis Species 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- 150000000996 L-ascorbic acids Chemical class 0.000 description 1
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 1
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 102000010445 Lactoferrin Human genes 0.000 description 1
- 108010063045 Lactoferrin Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- UEEJHVSXFDXPFK-UHFFFAOYSA-N N-dimethylaminoethanol Chemical compound CN(C)CCO UEEJHVSXFDXPFK-UHFFFAOYSA-N 0.000 description 1
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 1
- 108010064719 Oxyhemoglobins Proteins 0.000 description 1
- 241001085205 Prenanthella exigua Species 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 241000241413 Propolis Species 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- 206010039792 Seborrhoea Diseases 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003537 Vitamin B3 Natural products 0.000 description 1
- 229930003571 Vitamin B5 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- 208000000260 Warts Diseases 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- 229940100228 acetyl coenzyme a Drugs 0.000 description 1
- 229960004308 acetylcysteine Drugs 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 150000003862 amino acid derivatives Chemical class 0.000 description 1
- 239000000058 anti acne agent Substances 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 230000001857 anti-mycotic effect Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 229940124340 antiacne agent Drugs 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000002543 antimycotic Substances 0.000 description 1
- 239000003096 antiparasitic agent Substances 0.000 description 1
- 229940125687 antiparasitic agent Drugs 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 125000003289 ascorbyl group Chemical group [H]O[C@@]([H])(C([H])([H])O*)[C@@]1([H])OC(=O)C(O*)=C1O* 0.000 description 1
- 235000010385 ascorbyl palmitate Nutrition 0.000 description 1
- XNEFYCZVKIDDMS-UHFFFAOYSA-N avobenzone Chemical compound C1=CC(OC)=CC=C1C(=O)CC(=O)C1=CC=C(C(C)(C)C)C=C1 XNEFYCZVKIDDMS-UHFFFAOYSA-N 0.000 description 1
- 229960005193 avobenzone Drugs 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 229960003328 benzoyl peroxide Drugs 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 229940095259 butylated hydroxytoluene Drugs 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- 150000001783 ceramides Chemical class 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 229940110767 coenzyme Q10 Drugs 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 150000001879 copper Chemical class 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- ORTQZVOHEJQUHG-UHFFFAOYSA-L copper(II) chloride Chemical compound Cl[Cu]Cl ORTQZVOHEJQUHG-UHFFFAOYSA-L 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 108010002255 deoxyhemoglobin Proteins 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 229960003949 dexpanthenol Drugs 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 239000002532 enzyme inhibitor Substances 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 238000000695 excitation spectrum Methods 0.000 description 1
- 210000004709 eyebrow Anatomy 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 238000002073 fluorescence micrograph Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 238000009432 framing Methods 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 229940045109 genistein Drugs 0.000 description 1
- 235000006539 genistein Nutrition 0.000 description 1
- TZBJGXHYKVUXJN-UHFFFAOYSA-N genistein Natural products C1=CC(O)=CC=C1C1=COC2=CC(O)=CC(O)=C2C1=O TZBJGXHYKVUXJN-UHFFFAOYSA-N 0.000 description 1
- ZCOLJUOHXJRHDI-CMWLGVBASA-N genistein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 ZCOLJUOHXJRHDI-CMWLGVBASA-N 0.000 description 1
- 235000003969 glutathione Nutrition 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 108010038983 glycyl-histidyl-lysine Proteins 0.000 description 1
- 229940087559 grape seed Drugs 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 239000005337 ground glass Substances 0.000 description 1
- 239000003324 growth hormone secretagogue Substances 0.000 description 1
- 239000007954 growth retardant Substances 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 229960004881 homosalate Drugs 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 229960004337 hydroquinone Drugs 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 229930013032 isoflavonoid Natural products 0.000 description 1
- 150000003817 isoflavonoid derivatives Chemical class 0.000 description 1
- 235000012891 isoflavonoids Nutrition 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 239000003410 keratolytic agent Substances 0.000 description 1
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 229940099563 lactobionic acid Drugs 0.000 description 1
- 229940078795 lactoferrin Drugs 0.000 description 1
- 235000021242 lactoferrin Nutrition 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 230000005055 memory storage Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229960001679 octinoxate Drugs 0.000 description 1
- 229960003921 octisalate Drugs 0.000 description 1
- WCJLCOAEJIHPCW-UHFFFAOYSA-N octyl 2-hydroxybenzoate Chemical compound CCCCCCCCOC(=O)C1=CC=CC=C1O WCJLCOAEJIHPCW-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 230000037312 oily skin Effects 0.000 description 1
- 239000003605 opacifier Substances 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000013307 optical fiber Substances 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 210000004694 pigment cell Anatomy 0.000 description 1
- 235000010204 pine bark Nutrition 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 229960002429 proline Drugs 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 229940069949 propolis Drugs 0.000 description 1
- 230000001012 protector Effects 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229960001755 resorcinol Drugs 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 210000004378 sebocyte Anatomy 0.000 description 1
- 230000037307 sensitive skin Effects 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 201000010153 skin papilloma Diseases 0.000 description 1
- 230000036548 skin texture Effects 0.000 description 1
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 1
- 229940001584 sodium metabisulfite Drugs 0.000 description 1
- 235000010262 sodium metabisulphite Nutrition 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 235000001508 sulfur Nutrition 0.000 description 1
- 229960005349 sulfur Drugs 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 125000002640 tocopherol group Chemical class 0.000 description 1
- 235000019149 tocopherols Nutrition 0.000 description 1
- 229930003802 tocotrienol Natural products 0.000 description 1
- 239000011731 tocotrienol Substances 0.000 description 1
- 235000019148 tocotrienols Nutrition 0.000 description 1
- 229940068778 tocotrienols Drugs 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 229960001727 tretinoin Drugs 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- 239000010937 tungsten Substances 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 229960004441 tyrosine Drugs 0.000 description 1
- 229940035936 ubiquinone Drugs 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 238000002460 vibrational spectroscopy Methods 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019160 vitamin B3 Nutrition 0.000 description 1
- 239000011708 vitamin B3 Substances 0.000 description 1
- 235000009492 vitamin B5 Nutrition 0.000 description 1
- 239000011675 vitamin B5 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 229940118846 witch hazel Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/44—Detecting, measuring or recording for evaluating the integumentary system, e.g. skin, hair or nails
- A61B5/441—Skin evaluation, e.g. for skin disorder diagnosis
- A61B5/445—Evaluating skin irritation or skin trauma, e.g. rash, eczema, wound, bed sore
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0062—Arrangements for scanning
- A61B5/0064—Body surface scanning
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0071—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence by measuring fluorescence emission
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0075—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence by spectroscopy, i.e. measuring spectra, e.g. Raman spectroscopy, infrared absorption spectroscopy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/44—Detecting, measuring or recording for evaluating the integumentary system, e.g. skin, hair or nails
- A61B5/441—Skin evaluation, e.g. for skin disorder diagnosis
- A61B5/442—Evaluating skin mechanical properties, e.g. elasticity, hardness, texture, wrinkle assessment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/44—Detecting, measuring or recording for evaluating the integumentary system, e.g. skin, hair or nails
- A61B5/441—Skin evaluation, e.g. for skin disorder diagnosis
- A61B5/443—Evaluating skin constituents, e.g. elastin, melanin, water
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/44—Detecting, measuring or recording for evaluating the integumentary system, e.g. skin, hair or nails
- A61B5/441—Skin evaluation, e.g. for skin disorder diagnosis
- A61B5/444—Evaluating skin marks, e.g. mole, nevi, tumour, scar
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04N—PICTORIAL COMMUNICATION, e.g. TELEVISION
- H04N23/00—Cameras or camera modules comprising electronic image sensors; Control thereof
- H04N23/60—Control of cameras or camera modules
- H04N23/66—Remote control of cameras or camera parts, e.g. by remote control devices
- H04N23/663—Remote control of cameras or camera parts, e.g. by remote control devices for controlling interchangeable camera parts based on electronic image sensor signals
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04N—PICTORIAL COMMUNICATION, e.g. TELEVISION
- H04N23/00—Cameras or camera modules comprising electronic image sensors; Control thereof
- H04N23/70—Circuitry for compensating brightness variation in the scene
- H04N23/74—Circuitry for compensating brightness variation in the scene by influencing the scene brightness using illuminating means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/44—Detecting, measuring or recording for evaluating the integumentary system, e.g. skin, hair or nails
- A61B5/441—Skin evaluation, e.g. for skin disorder diagnosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
- Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
Abstract
Description
Claims (16)
- REIVINDICAÇÕES1. Método de captura de dados sobre a pele de uma pessoa compreendendo as etapas de:(A) proporcionar uma estação de formação de imagem (200,500,600) tendo uma câmera (211), uma fonte de luz (716,814), um visor (270) para exibição de imagens capturadas pela câmera (211); pelo menos uma sonda (234,718) para a medição de um parâmetro da pele em uma área específica, um controlador com uma interface de operador;(B) posicionar a pessoa em relação à câmera (211); caracterizado pelo fato de que ainda compreende as etapas de:(C) proporcionar a pessoa com as opções de captura de imagens com a câmera (211) ou obter dados de pele com a sonda (234,718);(D) implementar a opção selecionada na etapa (C);(E) quando a opção selecionada é obter dados da pele com a sonda (234,718), ao mesmo tempo em que é realizada a etapa (D), capturar uma imagem estática da pessoa, a imagem estática registrando a posição da sonda (234,718) quando a etapa ( D) é realizada;(F) armazenar os dados capturados com a câmera (211) e a sonda (234,718); e (G) exibir seletivamente os dados capturados no visor (270).
- 2. Método, de acordo com a reivindicação 1, caracterizado pelo fato de que a etapa (D) inclui exibir uma imagem em tempo real da pessoa para permitir que a pessoa visualize e interativamente ajuste a posição da sonda (234,718), habilitando a sonda e ativando a sonda para a captura de dados da pele.
- 3. Método, de acordo com a reivindicação 2, caracterizadoPetição 870180053521, de 21/06/2018, pág. 52/592/3 pelo fato de que a estação de formação de imagem (200,500,600) tem uma pluralidade de fontes de luz de comprimentos de onda diferentes e as imagens capturadas pela câmera (211) incluem imagens capturadas com diferentes comprimentos de onda de luz.
- 4. Método, de acordo com a reivindicação 3, caracterizado pelo fato de que ainda compreende repetir as etapas de habilitação da sonda (234,718) e ativação da sonda um número selecionado de vezes para capturar dados adicionais.
- 5. Método, de acordo com a reivindicação 4, caracterizado pelo fato de que a posição da sonda em pelo menos em uma ocasião da ativação é determinada com referência a uma imagem fotográfica da pessoa tomada em um tempo removido a partir do tempo de ativação.
- 6. Método, de acordo com a reivindicação 4, caracterizado pelo fato de que a sonda é movida para pelo menos uma posição diferente na superfície da pele da pessoa entre as etapas seqüenciais de ativação.
- 7. Método, de acordo com qualquer uma das reivindicações 1 a 6, caracterizado pelo fato de que ainda compreende proporcionar instruções para auto-uso da estação de formação de imagem/sonda para o usuário da mesma na forma de pelo menos uma dentre instruções de texto, gráficas e auditivas.
- 8. Método, de acordo com qualquer uma das reivindicações 1 a 7, caracterizado pelo fato de que compreende realizar espectroscopia de reflectância difusa sobre a pele usando um espectrômetro.
- 9. Método, de acordo com a reivindicação 8, caracterizado pelo fato de que compreende usar uma sonda (718) que é conectada a uma fonte de luz (716) através de um feixe de fibra ótica bifurcado (724), em que o através de um feixe de fibra ótica bifurcado (724)Petição 870180053521, de 21/06/2018, pág. 53/593/3 compreende uma fibra de iluminação e uma fibra de coleta.
- 10. Método, de acordo com qualquer uma das reivindicações 1 a 7, caracterizado pelo fato de que compreende realizar espectroscopia de fluorescência sobre a pele.Petição 870180053521, de 21/06/2018, pág. 54/59 £|ΟLL • · • · · • ·» · a · · · « a ♦ ·2/16 ·· ···· • · • · · · > · · a ·· aaa · • » · · a a ·*«· a a a · · • * · · • a a a aFIG 3 ««« χίΟ mΟLL· > · ♦ <• · ♦ • · · « • · · · • · · ·5/16I · · « · · • · • · · · »· · · • · · »« · ·Α^ ( FIM Κ'FIG 66/16308FIG 7 • · · · · · • · · • «ftftft • · · · • · · • · ft ft7/16FIG 8 • · · · ·· · <• * 1 ♦ · · ·8/16 /;CAPTURAR Ε ARMAZENAR DADOS DE ' SONDA315EXIBIR MENUDE SONDASDISPONÍVEIS3η * · • · · • · <► · · • · «»··«··· ·* · , « · · · · · ► · · · · /503« •38|FIG 99 · · · » · · * > · · · · k « « · · · k · . · · 9 9 » » ·*·····’ V · « · * * * • · » · · · * • » 4 «· · ·9/16EXIBIR IMAGENS E PROVER OPÇÕES DE CONTROLE DE OPERADOR PARA O OPERADOR o• · ί · • ·10/16FIG 11 • a • · · ·
- 11/16 . a ·a a a ·«······ ·· • aa ··· · · · · a a a * · a a a · ·* J·*· • a a · a a aa · · · a a aa aa aa aa ·· · aa aa aa aa a aa aaFIG 12 ··· ··· ···
- 12/16FIG 13 ··· ·»· * aaaa a a a » aaa · ·
- 13/16 aaa aa aaaa • a a a • a aaaa a aaa « a · · » a a a a a
- 14/16 • ft · ft »♦ ft · • * ft « · • · ft ft · · • « • ft ft ft ftftft···· • ft · ftftft «ftftft · ft ft ft · · ft ft ft · · ft • ft ft ft · ft · • «· ·♦·· • ft · ft ft · ftftft • ft · ft ft · « • ft ft ·FIG 16 • · · · · ·C · t fr * · ♦ ·· · • · * • · · ·
- 15/16FIG 17FIG 18I * » «« · Φ ·····»· • · t · » I • ··♦ · · ··· · • «4 · · · · · • < « · · · · · · * ·· » · · · · · ·73oCOMPRIMENTO DE ONDA (nm)COMPRIMENTO DE ONDA (nm) ·* ···· • · • ·»· ··· · • · · ··
- 16/16 • * ··· « ·· ♦······· ·· . 1 > ···· · · » « · * · * · · ?η·FIG 19 «3οCOMPRIMENTO DE ONDA DE EXCITAÇÃO (nm)FIG 20
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/169,813 US8026942B2 (en) | 2004-10-29 | 2005-06-29 | Skin imaging system with probe |
Publications (3)
Publication Number | Publication Date |
---|---|
BRPI0605795A BRPI0605795A (pt) | 2007-05-08 |
BRPI0605795B1 true BRPI0605795B1 (pt) | 2018-09-25 |
BRPI0605795B8 BRPI0605795B8 (pt) | 2023-03-07 |
Family
ID=43127735
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0605795A BRPI0605795B8 (pt) | 2005-06-29 | 2006-06-29 | sistema de formação de imagem de pele com prova |
Country Status (4)
Country | Link |
---|---|
US (1) | US8026942B2 (pt) |
EP (2) | EP2289413B1 (pt) |
BR (1) | BRPI0605795B8 (pt) |
CA (1) | CA2551311C (pt) |
Families Citing this family (103)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040146290A1 (en) * | 2001-11-08 | 2004-07-29 | Nikiforos Kollias | Method of taking images of the skin using blue light and the use thereof |
US6922523B2 (en) * | 2001-11-08 | 2005-07-26 | Johnson & Johnson Consumer Companies, Inc. | Method of promoting skin care products |
US7738032B2 (en) * | 2001-11-08 | 2010-06-15 | Johnson & Johnson Consumer Companies, Inc. | Apparatus for and method of taking and viewing images of the skin |
FR2878424B1 (fr) * | 2004-11-26 | 2008-02-01 | Oreal | Procede d'observation d'un tissu biologique, notamment de la peau humaine |
US7657101B2 (en) * | 2005-01-19 | 2010-02-02 | Dermaspect, Llc | Devices and methods for identifying and monitoring changes of a suspect area on a patient |
ES2432515T3 (es) * | 2005-04-28 | 2013-12-04 | Shiseido Company, Limited | Método de análisis del estado de la piel, aparato de análisis del estado de la piel y medio legible por ordenador que almacena un programa de análisis del estado de la piel |
CA2985955C (en) | 2005-08-12 | 2020-07-07 | Tcms Transparent Beauty Llc | System and method for medical monitoring and treatment through cosmetic monitoring and treatment |
US8861863B2 (en) * | 2005-09-20 | 2014-10-14 | Brightex Bio-Photonics Llc | Method and system for analyzing lip conditions using digital images |
WO2007043899A1 (en) | 2005-10-14 | 2007-04-19 | Applied Research Associates Nz Limited | A method of monitoring a surface feature and apparatus therefor |
US20070200337A1 (en) * | 2006-02-27 | 2007-08-30 | Aaron Henry Johnson | Method for creating a decoy exhibiting realistic spectral reflectance |
US8882267B2 (en) | 2006-03-20 | 2014-11-11 | High Performance Optics, Inc. | High energy visible light filter systems with yellowness index values |
US20120075577A1 (en) | 2006-03-20 | 2012-03-29 | Ishak Andrew W | High performance selective light wavelength filtering providing improved contrast sensitivity |
US8184901B2 (en) | 2007-02-12 | 2012-05-22 | Tcms Transparent Beauty Llc | System and method for applying a reflectance modifying agent to change a person's appearance based on a digital image |
US8189887B2 (en) * | 2006-10-02 | 2012-05-29 | Johnson & Johnson Consumer Companies, Inc. | Imaging standard apparatus and method |
US20080080766A1 (en) * | 2006-10-02 | 2008-04-03 | Gregory Payonk | Apparatus and Method for Analyzing Skin Using L*a*b* Colorspace |
US7764303B2 (en) * | 2006-10-02 | 2010-07-27 | Johnson & Johnson Consumer Companies, Inc. | Imaging apparatus and methods for capturing and analyzing digital images of the skin |
US7558416B2 (en) * | 2006-10-02 | 2009-07-07 | Johnson & Johnson Consumer Companies, Inc. | Apparatus and method for measuring photodamage to skin |
US8107696B2 (en) | 2006-10-02 | 2012-01-31 | Johnson & Johnson Consumer Companies, Inc. | Calibration apparatus and method for fluorescent imaging |
US8103061B2 (en) * | 2006-10-02 | 2012-01-24 | Johnson & Johnson Consumer Companies, Inc. | Method and apparatus for identifying facial regions |
CN101641161B (zh) | 2007-02-12 | 2012-04-18 | Tcms剔透美丽有限责任公司 | 用于向人类皮肤静电施与试剂的系统和方法 |
US8081355B2 (en) * | 2007-03-05 | 2011-12-20 | Ricoh Company, Ltd. | Illumination unit, image read apparatus, image formation apparatus |
US8098900B2 (en) * | 2007-03-06 | 2012-01-17 | Honeywell International Inc. | Skin detection sensor |
US10092082B2 (en) | 2007-05-29 | 2018-10-09 | Tcms Transparent Beauty Llc | Apparatus and method for the precision application of cosmetics |
US20080312952A1 (en) * | 2007-06-12 | 2008-12-18 | Gulfo Joseph V | Regulating Use Of A Device To Perform A Procedure On A Subject |
WO2009005748A1 (en) | 2007-06-29 | 2009-01-08 | The Trustees Of Columbia University In The City Ofnew York | Optical imaging or spectroscopy systems and methods |
US7929050B2 (en) * | 2007-06-29 | 2011-04-19 | Epson America, Inc. | Document camera |
JP5361159B2 (ja) | 2007-09-06 | 2013-12-04 | キヤノン株式会社 | 画像表示制御装置、その制御方法、プログラム、および記録媒体 |
US20090102933A1 (en) * | 2007-09-24 | 2009-04-23 | Global Device Management | Target Acquisition System |
EP2040061A1 (en) | 2007-09-24 | 2009-03-25 | Koninklijke Philips Electronics N.V. | An apparatus and method for observing the surface of a sample |
EP2195638A1 (en) * | 2007-09-24 | 2010-06-16 | Koninklijke Philips Electronics N.V. | An apparatus for observing the surface of a sample |
US20090118600A1 (en) * | 2007-11-02 | 2009-05-07 | Ortiz Joseph L | Method and apparatus for skin documentation and analysis |
US8849380B2 (en) * | 2007-11-26 | 2014-09-30 | Canfield Scientific Inc. | Multi-spectral tissue imaging |
WO2009086465A1 (en) * | 2007-12-27 | 2009-07-09 | Saje Holdings, Inc. | A lighting system and control method thereof |
PT2291640T (pt) | 2008-05-20 | 2019-02-26 | Univ Health Network | Dispositivo e método para imagiologia e monitorização baseados em fluorescência |
US20190215449A1 (en) | 2008-09-05 | 2019-07-11 | Telefonaktiebolaget Lm Ericsson (Publ) | Mobile terminal and method of performing multi-focusing and photographing image including plurality of objects using the same |
US8913176B2 (en) | 2008-09-05 | 2014-12-16 | Lg Electronics Inc. | Mobile terminal and method of performing multi-focusing and photographing image including plurality of objects using the same |
FR2935888B1 (fr) * | 2008-09-17 | 2010-09-24 | Dataderm Internat Gmbh | Procede et systeme d'analyse de la peau |
EP2223650A1 (en) * | 2009-02-25 | 2010-09-01 | The Provost, Fellows and Scholars of the College of the Holy and Undivided Trinity of Queen Elizabeth near Dublin | Method and apparatus for imaging tissue topography |
US8319857B2 (en) * | 2009-02-26 | 2012-11-27 | Access Business Group International Llc | Apparatus and method for correcting digital color photographs |
US8373859B2 (en) * | 2009-03-27 | 2013-02-12 | Brightex Bio-Photonics Llc | Methods and systems for imaging skin using polarized lighting |
US8823934B2 (en) * | 2009-03-27 | 2014-09-02 | Brightex Bio-Photonics Llc | Methods and systems for imaging and modeling skin using polarized lighting |
US8330807B2 (en) * | 2009-05-29 | 2012-12-11 | Convergent Medical Solutions, Inc. | Automated assessment of skin lesions using image library |
JP5429460B2 (ja) * | 2009-06-10 | 2014-02-26 | 株式会社ニコン | 肌診断装置 |
US8606345B2 (en) * | 2009-08-31 | 2013-12-10 | Gsm Of Kansas, Inc. | Medical dual lens camera for documentation of dermatological conditions with laser distance measuring |
US8433116B2 (en) * | 2009-11-03 | 2013-04-30 | Mela Sciences, Inc. | Showing skin lesion information |
US8452063B2 (en) | 2009-11-03 | 2013-05-28 | Mela Sciences, Inc. | Showing skin lesion information |
US8490321B1 (en) | 2009-11-04 | 2013-07-23 | Scott A. Butz | UV reflective fishing lure system |
CN101719984B (zh) * | 2009-11-09 | 2012-06-06 | 无锡中星微电子有限公司 | 一种图像处理的装置 |
GB2484656A (en) * | 2010-10-12 | 2012-04-25 | Ovie Ltd | Image capture method and apparatus for recording images of a patients eye, ear and/or tongue |
FR2969915B1 (fr) * | 2011-01-04 | 2014-01-03 | Ergylink | Systeme et procede pour analyser au moins une caracteristique de la peau |
EP2710514A4 (en) * | 2011-05-18 | 2015-04-01 | Nextgenid Inc | REGISTRATION TERMINAL HAVING MULTIPLE BIOMETRIC APPARATUSES INCLUDING BIOMETRIC INSCRIPTION AND VERIFICATION SYSTEMS, FACIAL RECOGNITION AND COMPARISON OF FINGERPRINTS |
US8804122B2 (en) | 2011-09-22 | 2014-08-12 | Brightex Bio-Photonics Llc | Systems and methods for determining a surface profile using a plurality of light sources |
US9179844B2 (en) | 2011-11-28 | 2015-11-10 | Aranz Healthcare Limited | Handheld skin measuring or monitoring device |
US9155473B2 (en) * | 2012-03-21 | 2015-10-13 | Korea Electrotechnology Research Institute | Reflection detection type measurement apparatus for skin autofluorescence |
US9173570B2 (en) * | 2012-04-12 | 2015-11-03 | Thomas Nathan Millikan | Viewing and processing multispectral images |
US20150078642A1 (en) * | 2012-04-24 | 2015-03-19 | The General Hospital Corporation | Method and system for non-invasive quantification of biologial sample physiology using a series of images |
WO2013169326A1 (en) * | 2012-05-07 | 2013-11-14 | DermSpectra LLC | System and apparatus for automated total body imaging |
US9462872B2 (en) | 2012-08-27 | 2016-10-11 | Tcms Transparent Beauty, Llc | Printer head with prism for sensing |
JP2014061057A (ja) * | 2012-09-20 | 2014-04-10 | Sony Corp | 情報処理装置、情報処理方法、プログラム、及び測定システム |
US9060674B2 (en) | 2012-10-11 | 2015-06-23 | Karl Storz Imaging, Inc. | Auto zoom for video camera |
US20140243684A1 (en) * | 2013-02-27 | 2014-08-28 | DermSpectra LLC | System and method for creating, processing, and displaying total body image |
USD743553S1 (en) | 2013-02-28 | 2015-11-17 | DermSpectra LLC | Imaging booth |
US9888855B2 (en) * | 2013-03-18 | 2018-02-13 | Korea Electrotechnology Research Institute | Reflection detection type measurement apparatus and method for skin autofluorescence |
US20150201840A1 (en) * | 2013-03-18 | 2015-07-23 | Korea Electrotechnology Research Institute | Reflection detection type measurement apparatus for skin autofluorescence |
US9256963B2 (en) | 2013-04-09 | 2016-02-09 | Elc Management Llc | Skin diagnostic and image processing systems, apparatus and articles |
US9101320B2 (en) | 2013-04-09 | 2015-08-11 | Elc Management Llc | Skin diagnostic and image processing methods |
TWI494068B (zh) * | 2013-04-23 | 2015-08-01 | Genesis Photonics Inc | 保護套 |
US9662061B2 (en) * | 2013-12-16 | 2017-05-30 | International Business Machines Corporation | Ultraviolet camera and display station for capturing reflected ultraviolet light |
TWI696450B (zh) * | 2014-04-16 | 2020-06-21 | 日商新力股份有限公司 | 資訊處理裝置、資訊處理系統、及資訊處理程式 |
KR20150120774A (ko) * | 2014-04-18 | 2015-10-28 | 삼성전자주식회사 | 관심영역 검출 시스템 및 방법 |
US10368795B2 (en) * | 2014-06-30 | 2019-08-06 | Canfield Scientific, Incorporated | Acne imaging methods and apparatus |
CA2955976A1 (en) | 2014-07-24 | 2016-01-28 | University Health Network | Collection and analysis of data for diagnostic purposes |
WO2016057633A1 (en) | 2014-10-08 | 2016-04-14 | Revealix, Inc. | Automated systems and methods for skin assessment and early detection of a latent pathogenic bio-signal anomaly |
US10664686B2 (en) * | 2014-11-04 | 2020-05-26 | Samsung Electronics Co., Ltd. | Electronic device, and method for analyzing face information in electronic device |
WO2016134942A1 (en) * | 2015-02-27 | 2016-09-01 | Fotonation Limited | An optical system for an image acquisition device |
WO2016183075A1 (en) | 2015-05-12 | 2016-11-17 | Profoot, Inc. | Real time ultraviolet light reflectance imaging |
AU2017217455C1 (en) | 2016-02-08 | 2019-01-17 | Sephora USA Inc. | Apparatus and method for formulation and dispensing of visually customized cosmetics |
WO2017189923A2 (en) * | 2016-04-27 | 2017-11-02 | Voxelight, Llc | Imaging device for assessing sunscreen coverage |
US10013527B2 (en) | 2016-05-02 | 2018-07-03 | Aranz Healthcare Limited | Automatically assessing an anatomical surface feature and securely managing information related to the same |
WO2018001727A1 (en) * | 2016-06-27 | 2018-01-04 | Koninklijke Philips N.V. | Device and method for skin gloss detection |
US10511777B2 (en) | 2016-11-08 | 2019-12-17 | Thomas Nichols | Personal care device with camera |
US11122206B2 (en) | 2016-11-08 | 2021-09-14 | Preh Holding, Llc | Personal care device with camera |
US11116407B2 (en) | 2016-11-17 | 2021-09-14 | Aranz Healthcare Limited | Anatomical surface assessment methods, devices and systems |
HUP1600669A2 (en) * | 2016-12-14 | 2018-06-28 | Handinscan Zrt | Method, apparatus and computer program product for hand disinfection quality control |
EP4183328A1 (en) | 2017-04-04 | 2023-05-24 | Aranz Healthcare Limited | Anatomical surface assessment methods, devices and systems |
US10938950B2 (en) * | 2017-11-14 | 2021-03-02 | General Electric Company | Hierarchical data exchange management system |
DE102017222530A1 (de) * | 2017-12-12 | 2019-06-13 | Henkel Ag & Co. Kgaa | Anordnung zum Ermitteln von Stoffwechselendprodukten in der Haut |
WO2019148116A1 (en) | 2018-01-29 | 2019-08-01 | Atolla Skin Health, Inc. | Systems and methods for formulating personalized skincare products |
US10575623B2 (en) | 2018-06-29 | 2020-03-03 | Sephora USA, Inc. | Color capture system and device |
KR102548317B1 (ko) | 2018-07-16 | 2023-06-26 | 아너 디바이스 컴퍼니 리미티드 | 색소 검출 방법 및 전자 장치 |
WO2020014779A1 (en) * | 2018-07-16 | 2020-01-23 | Swift Medical Inc. | Apparatus for visualization of tissue |
CN109381165B (zh) * | 2018-09-12 | 2022-05-03 | 维沃移动通信有限公司 | 一种皮肤检测方法及移动终端 |
USD1000624S1 (en) | 2019-12-27 | 2023-10-03 | Thomas Nichols | Personal care device with camera |
WO2021150812A1 (en) * | 2020-01-23 | 2021-07-29 | Precision Healing, Inc. | Exudate analysis using optical signatures |
KR20210152179A (ko) * | 2020-06-08 | 2021-12-15 | 주식회사 휴먼피부임상시험센터 | 시리얼 피부 유형 분석과 맞춤형 화장품 조제 장치 |
WO2022043975A1 (en) * | 2020-08-31 | 2022-03-03 | Trieye Ltd. | Systems, methods and computer program products for skin liquid levels estimation |
FR3115602A1 (fr) * | 2020-10-22 | 2022-04-29 | L'oreal | Procede et appareil de detection d’ecran solaire sur de la peau ayant diverses couches de produit cosmetique |
CN116209893A (zh) * | 2020-09-29 | 2023-06-02 | 莱雅公司 | 用于检测具有各种化妆品层的皮肤上的防晒霜的方法和装置 |
JP2022084299A (ja) * | 2020-11-26 | 2022-06-07 | マクセル株式会社 | 肌状態測定システム |
JP2022138384A (ja) * | 2021-03-10 | 2022-09-26 | マクセル株式会社 | 肌状態測定システム |
WO2024075064A1 (en) * | 2022-10-05 | 2024-04-11 | Eyecare Spa | Methods and apparatus for detection of optical diseases |
US11837019B1 (en) | 2023-09-26 | 2023-12-05 | Dauntless Labs, Llc | Evaluating face recognition algorithms in view of image classification features affected by smart makeup |
CN117542127A (zh) * | 2024-01-09 | 2024-02-09 | 南方科技大学 | 基于多光谱偏振光的皮肤检测方法及装置 |
Family Cites Families (95)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3353884A (en) | 1966-03-08 | 1967-11-21 | William H Chaffee | Compact multi-purpose display module |
JPS564889B2 (pt) | 1972-09-22 | 1981-02-02 | ||
US3904293A (en) | 1973-12-06 | 1975-09-09 | Sherman Gee | Optical method for surface texture measurement |
US4170987A (en) | 1977-11-28 | 1979-10-16 | California Institute Of Technology | Medical diagnosis system and method with multispectral imaging |
US4398541A (en) | 1978-05-25 | 1983-08-16 | Xienta, Inc. | Method and apparatus for measuring moisture content of skin |
GB2106241B (en) | 1981-09-25 | 1985-06-12 | Welsh Nat School Med | Measuring surface roughness |
DE3176658D1 (en) * | 1981-12-10 | 1988-03-31 | Revlon | Process for making metallic leafing pigments |
US5311293A (en) | 1983-07-18 | 1994-05-10 | Chromatics Color Sciences International, Inc. | Method and instrument for selecting personal compatible colors |
GB8514052D0 (en) | 1985-06-04 | 1985-07-10 | Geistlich Soehne Ag | Compositions |
FR2587181B1 (fr) | 1985-09-16 | 1987-12-18 | Bourdier Jean Claude | Procede et dispositif de maquillage |
JPS6459145A (en) | 1987-08-31 | 1989-03-06 | Kao Corp | Analyzer of surface nature |
US4911544A (en) | 1987-11-13 | 1990-03-27 | Walsh John P | Skin condition analyzer for cosmetologists |
US5016173A (en) | 1989-04-13 | 1991-05-14 | Vanguard Imaging Ltd. | Apparatus and method for monitoring visually accessible surfaces of the body |
US5241468A (en) | 1989-04-13 | 1993-08-31 | Vanguard Imaging Ltd. | Apparatus and method for spectral enhancement of body-surface images to improve sensitivity of detecting subtle color features |
FR2665959B1 (fr) | 1990-08-16 | 1994-01-14 | Oreal | Appareil destine a permettre d'evaluer la brillance d'une surface, en particulier de la peau. |
DE4026821A1 (de) | 1990-08-24 | 1992-03-05 | Philips Patentverwaltung | Verfahren zur erfassung von anomalien der haut, insbesondere von melanomen, sowie vorrichtung zur durchfuehrung des verfahrens |
US5408996A (en) * | 1993-03-25 | 1995-04-25 | Salb; Jesse | System and method for localization of malignant tissue |
DE4313258A1 (de) | 1993-04-23 | 1994-10-27 | Beiersdorf Ag | Verfahren und Vorrichtung zur meßtechnischen quantitativen Bestimmung der Textur der menschlichen Hautoberfläche durch Registrierung, Wiedergabe und Analysierung von Bildinformationen |
JPH0775629A (ja) | 1993-09-07 | 1995-03-20 | Kao Corp | 皮膚表面観察方法及び皮膚表面観察装置 |
US5640957A (en) | 1993-09-29 | 1997-06-24 | Instruments Sa, Inc. | Ultraviolet radiation protection evaluator |
US5556612A (en) | 1994-03-15 | 1996-09-17 | The General Hospital Corporation | Methods for phototherapeutic treatment of proliferative skin diseases |
US5590660A (en) | 1994-03-28 | 1997-01-07 | Xillix Technologies Corp. | Apparatus and method for imaging diseased tissue using integrated autofluorescence |
US5456260A (en) | 1994-04-05 | 1995-10-10 | The General Hospital Corporation | Fluorescence detection of cell proliferation |
JPH07323014A (ja) | 1994-06-01 | 1995-12-12 | Kao Corp | 皮膚表面観察装置 |
GB2293648B (en) | 1994-09-27 | 1998-10-28 | Atomic Energy Authority Uk | Pulsed ultra-violet fluoroscopy |
AT403654B (de) | 1994-12-01 | 1998-04-27 | Binder Michael Dr | Einrichtung zur optischen untersuchung von human-haut sowie derselben zugeordnete auswertungs-einrichtung |
JP2776294B2 (ja) | 1995-04-12 | 1998-07-16 | 日本電気株式会社 | 皮膚紋様画像の画像特徴抽出装置および画像処理装置 |
US5666159A (en) * | 1995-04-24 | 1997-09-09 | Eastman Kodak Company | Electronic camera system with programmable transmission capability |
WO1997005473A1 (en) | 1995-08-01 | 1997-02-13 | Medispectra, Inc. | Optical microprobes and methods for spectral analysis of materials |
ZA967500B (en) * | 1995-12-21 | 1998-03-05 | Unilever Plc | Device for the identification of acne, microcomedones, and bacteria on human skin. |
US5973779A (en) * | 1996-03-29 | 1999-10-26 | Ansari; Rafat R. | Fiber-optic imaging probe |
US5742392A (en) | 1996-04-16 | 1998-04-21 | Seymour Light, Inc. | Polarized material inspection apparatus |
US5828793A (en) | 1996-05-06 | 1998-10-27 | Massachusetts Institute Of Technology | Method and apparatus for producing digital images having extended dynamic ranges |
JPH09308619A (ja) | 1996-05-23 | 1997-12-02 | Kao Corp | 皮膚表面分析方法及び装置 |
IL118634A0 (en) | 1996-06-11 | 1996-10-16 | J M I Ltd | Dermal imaging diagnostic analysis system and method |
JPH104531A (ja) | 1996-06-14 | 1998-01-06 | Nikon Corp | 情報処理装置 |
CA2192036A1 (en) | 1996-12-04 | 1998-06-04 | Harvey Lui | Fluorescence scope system for dermatologic diagnosis |
US6441854B2 (en) * | 1997-02-20 | 2002-08-27 | Eastman Kodak Company | Electronic camera with quick review of last captured image |
US6081612A (en) | 1997-02-28 | 2000-06-27 | Electro Optical Sciences Inc. | Systems and methods for the multispectral imaging and characterization of skin tissue |
US6208749B1 (en) * | 1997-02-28 | 2001-03-27 | Electro-Optical Sciences, Inc. | Systems and methods for the multispectral imaging and characterization of skin tissue |
US6317624B1 (en) * | 1997-05-05 | 2001-11-13 | The General Hospital Corporation | Apparatus and method for demarcating tumors |
GB9709737D0 (en) | 1997-05-14 | 1997-07-02 | Chase Advanced Technologies | Portable presentation device |
US6134011A (en) | 1997-09-22 | 2000-10-17 | Hdi Instrumentation | Optical measurement system using polarized light |
CA2305721C (en) * | 1997-10-08 | 2009-02-24 | The General Hospital Corporation | Phototherapy methods and systems |
US6597392B1 (en) | 1997-10-14 | 2003-07-22 | Healthcare Vision, Inc. | Apparatus and method for computerized multi-media data organization and transmission |
US6619860B1 (en) * | 1997-11-14 | 2003-09-16 | Eastman Kodak Company | Photobooth for producing digitally processed images |
US6148092A (en) | 1998-01-08 | 2000-11-14 | Sharp Laboratories Of America, Inc | System for detecting skin-tone regions within an image |
US6177984B1 (en) | 1998-01-23 | 2001-01-23 | Providence Health System | Video imaging of superficial biological tissue layers using polarized light |
CA2318180A1 (en) | 1998-01-26 | 1999-07-29 | Massachusetts Institute Of Technology | Fluorescence imaging endoscope |
CA2230736C (en) | 1998-03-03 | 2007-02-06 | Donald G. Coburn | Dispensing cabinet |
US6721582B2 (en) * | 1999-04-06 | 2004-04-13 | Argose, Inc. | Non-invasive tissue glucose level monitoring |
US6728560B2 (en) | 1998-04-06 | 2004-04-27 | The General Hospital Corporation | Non-invasive tissue glucose level monitoring |
US6505059B1 (en) * | 1998-04-06 | 2003-01-07 | The General Hospital Corporation | Non-invasive tissue glucose level monitoring |
IL124616A0 (en) | 1998-05-24 | 1998-12-06 | Romedix Ltd | Apparatus and method for measurement and temporal comparison of skin surface images |
US6278999B1 (en) | 1998-06-12 | 2001-08-21 | Terry R. Knapp | Information management system for personal health digitizers |
DE59812335D1 (de) | 1998-09-30 | 2005-01-05 | Courage Brewing Ltd | Vorrichtung zur messtechnischen Erfassung von Parametern der Haut |
US6507747B1 (en) * | 1998-12-02 | 2003-01-14 | Board Of Regents, The University Of Texas System | Method and apparatus for concomitant structural and biochemical characterization of tissue |
US6352502B1 (en) * | 1998-12-03 | 2002-03-05 | Lightouch Medical, Inc. | Methods for obtaining enhanced spectroscopic information from living tissue, noninvasive assessment of skin condition and detection of skin abnormalities |
US6224542B1 (en) * | 1999-01-04 | 2001-05-01 | Stryker Corporation | Endoscopic camera system with non-mechanical zoom |
US6592882B2 (en) | 1999-05-26 | 2003-07-15 | Color Access, Inc. | Cosmetic compositions containing fluorescent minerals |
US6571003B1 (en) | 1999-06-14 | 2003-05-27 | The Procter & Gamble Company | Skin imaging and analysis systems and methods |
US6293284B1 (en) | 1999-07-07 | 2001-09-25 | Division Of Conopco, Inc. | Virtual makeover |
CA2385849A1 (en) | 1999-09-23 | 2001-03-29 | Richard G. Nadeau | Medical applications of orthogonal polarization spectral imaging |
JP4396873B2 (ja) | 1999-10-01 | 2010-01-13 | 株式会社資生堂 | 口紅又はアイシャドーの選択方法 |
US6993167B1 (en) | 1999-11-12 | 2006-01-31 | Polartechnics Limited | System and method for examining, recording and analyzing dermatological conditions |
US6624843B2 (en) * | 1999-12-10 | 2003-09-23 | Jerry W. Lennon | Customer image capture and use thereof in a retailing system |
US6603552B1 (en) * | 1999-12-22 | 2003-08-05 | Xillix Technologies Corp. | Portable system for detecting skin abnormalities based on characteristic autofluorescence |
WO2001045557A1 (en) | 1999-12-22 | 2001-06-28 | Xillix Technologies Corporation | Portable system for detecting skin abnormalities |
GB0004312D0 (en) | 2000-02-23 | 2000-04-12 | Oxagen Limited | Test and model for inflammatory disease |
WO2001072216A2 (en) * | 2000-03-28 | 2001-10-04 | Board Of Regents, The University Of Texas System | Methods and apparatus for diagnositic multispectral digital imaging |
US6889075B2 (en) | 2000-05-03 | 2005-05-03 | Rocky Mountain Biosystems, Inc. | Optical imaging of subsurface anatomical structures and biomolecules |
JP2002011106A (ja) * | 2000-06-28 | 2002-01-15 | Nidek Co Ltd | レーザ治療装置 |
WO2002007064A2 (en) * | 2000-07-17 | 2002-01-24 | Labnetics, Inc. | Method and apparatus for the processing of remotely collected electronic information characterizing properties of biological entities |
JP3884226B2 (ja) * | 2000-10-10 | 2007-02-21 | オリンパス株式会社 | 撮像システム |
JP2004533660A (ja) | 2000-10-18 | 2004-11-04 | ジヨンソン・アンド・ジヨンソン・コンシユーマー・カンパニーズ・インコーポレーテツド | 知能性能ベースの製品推奨システム |
FR2821152B3 (fr) | 2001-02-22 | 2003-03-14 | Hertsel Adhoute | Dispositif photographique de mesure sans contact et de representation 3d du micro relief cutane |
US20020181752A1 (en) * | 2001-03-14 | 2002-12-05 | Warren Wallo | Method for measuring changes in portions of a human body |
US6600947B2 (en) * | 2001-03-16 | 2003-07-29 | Nymox Corporation | Method of detecting amyloid-containing lesions by autofluorescence |
AU2002311571A1 (en) * | 2001-04-11 | 2002-12-16 | Cynovad, Inc. | Methods and systems for management of information related to the appearance of an object |
US6790179B2 (en) | 2001-08-01 | 2004-09-14 | Johnson & Johnson Consumer Companies, Inc. | Method of examining and diagnosing skin health |
US6926904B2 (en) | 2001-05-30 | 2005-08-09 | Unilever Home & Personal Care Usa, Division Of Conopco, Inc. | Cosmetic product with proof device |
FR2829344B1 (fr) * | 2001-08-29 | 2004-10-01 | Oreal | Dispositif d'acquisition d'au moins une image d'au moins une partie du visage ou de la chevelure d'une personne |
US7324668B2 (en) | 2001-10-01 | 2008-01-29 | L'oreal S.A. | Feature extraction in beauty analysis |
FR2831789B1 (fr) * | 2001-11-07 | 2004-01-23 | Oreal | Procede et dispositif pour l'evaluation de la secheresse cutanee notamment |
US6922523B2 (en) * | 2001-11-08 | 2005-07-26 | Johnson & Johnson Consumer Companies, Inc. | Method of promoting skin care products |
US6907193B2 (en) | 2001-11-08 | 2005-06-14 | Johnson & Johnson Consumer Companies, Inc. | Method of taking polarized images of the skin and the use thereof |
US6961517B2 (en) * | 2001-11-08 | 2005-11-01 | Johnson & Johnson Consumer Companies, Inc. | Method of promoting skin care products |
US20040146290A1 (en) | 2001-11-08 | 2004-07-29 | Nikiforos Kollias | Method of taking images of the skin using blue light and the use thereof |
US6711426B2 (en) * | 2002-04-09 | 2004-03-23 | Spectros Corporation | Spectroscopy illuminator with improved delivery efficiency for high optical density and reduced thermal load |
US20040077951A1 (en) * | 2002-07-05 | 2004-04-22 | Wei-Chiang Lin | Apparatus and methods of detection of radiation injury using optical spectroscopy |
US20040125996A1 (en) | 2002-12-27 | 2004-07-01 | Unilever Home & Personal Care Usa, Division Of Conopco, Inc. | Skin diagnostic imaging method and apparatus |
JP3984175B2 (ja) * | 2003-01-31 | 2007-10-03 | 富士フイルム株式会社 | 写真画像選別装置およびプログラム |
US7413567B2 (en) * | 2003-02-25 | 2008-08-19 | Spectragenics, Inc. | Optical sensor and method for identifying the presence of skin |
US9750449B2 (en) * | 2003-12-12 | 2017-09-05 | Johnson & Johnson Consumer Inc. | Method of assessing skin |
US7004599B2 (en) | 2004-01-02 | 2006-02-28 | 3Gen, Llc. | Illuminated mirror employing cross and parallel polarization |
-
2005
- 2005-06-29 US US11/169,813 patent/US8026942B2/en active Active
-
2006
- 2006-06-28 EP EP10180273.4A patent/EP2289413B1/en active Active
- 2006-06-28 EP EP06253363.3A patent/EP1738687B1/en active Active
- 2006-06-28 CA CA2551311A patent/CA2551311C/en active Active
- 2006-06-29 BR BRPI0605795A patent/BRPI0605795B8/pt active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
CA2551311A1 (en) | 2006-12-29 |
EP1738687A1 (en) | 2007-01-03 |
CA2551311C (en) | 2016-04-12 |
BRPI0605795B8 (pt) | 2023-03-07 |
EP2289413B1 (en) | 2016-11-16 |
BRPI0605795A (pt) | 2007-05-08 |
EP2289413A1 (en) | 2011-03-02 |
US8026942B2 (en) | 2011-09-27 |
EP1738687B1 (en) | 2015-01-14 |
US20060092315A1 (en) | 2006-05-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0605795B1 (pt) | sistema de formação de imagem de pele com prova | |
US7738032B2 (en) | Apparatus for and method of taking and viewing images of the skin | |
AU2005302482B2 (en) | Apparatus for and method of taking and viewing images of the skin | |
US7376346B2 (en) | Method of promoting skin care products | |
US6961517B2 (en) | Method of promoting skin care products | |
US6907193B2 (en) | Method of taking polarized images of the skin and the use thereof | |
US20060268148A1 (en) | Method of taking images of the skin using blue light and the use thereof | |
EP1433418A1 (en) | Skin diagnostic imaging method and apparatus | |
RU2657377C2 (ru) | Интеллектуальная насадка на смартфон для определения чистоты, влажности и фотовозраста кожи | |
EP1738688A2 (en) | Apparatus & method for viewing the skin | |
JP3984912B2 (ja) | 目の周りの領域を評価する方法及びかかる方法を実施する器械 | |
JP2008149107A (ja) | 皮膚疾患の光学診断および治療のための装置、光源システムおよび方法 | |
EP1617761B1 (en) | Method for assessing the efficacy of skin care products | |
Ardigò et al. | Non-invasive methods for vitiligo evaluation | |
Stephens et al. | Novel, Compelling, Noninvasive Techniques for Evaluating Cosmetic Products | |
WO2006050104A1 (en) | Apparatus for and method of taking and viewing images of the skin | |
Crowther et al. | Beyond the Visible: UV, IR and Fluorescence Imaging of the Skin | |
Matts et al. | Digital imaging as an effective means of recording and measuring the visual signs of skin aging | |
Ardigò et al. | In Vivo Data: Electron Microscopy | |
AU2015210412A1 (en) | System, device and method for dermal imaging |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 25/09/2018, OBSERVADAS AS CONDICOES LEGAIS. |
|
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 29/06/2006, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO |
|
B25G | Requested change of headquarter approved |
Owner name: JOHNSON AND JOHNSON CONSUMER COMPANIES, INC. (US) |
|
B25A | Requested transfer of rights approved |
Owner name: JOHNSON AND JOHNSON CONSUMER COMPANIES, LLC (US) |
|
B25A | Requested transfer of rights approved |
Owner name: MCNEIL-PPC, INC. (US) |
|
B25D | Requested change of name of applicant approved |
Owner name: JOHNSON AND JOHNSON CONSUMER INC. (US) |
|
B25A | Requested transfer of rights approved |
Owner name: CHENANGO ZERO LLC (US) |
|
B25A | Requested transfer of rights approved |
Owner name: CHENANGO TWO LLC (US) |
|
B25A | Requested transfer of rights approved |
Owner name: CURRAHEE HOLDING COMPANY INC. (US) |
|
B25D | Requested change of name of applicant approved |
Owner name: JOHNSON AND JOHNSON CONSUMER INC. (US) |
|
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: REFERENTE A RPI 2490 DE 25/09/2018, QUANTO AO ITEM (72) NOME DO INVENTOR. |
|
B25A | Requested transfer of rights approved |
Owner name: JOHNSON AND JOHNSON CONSUMER INC. (US) |